The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9498496 B1

PDF
Full Text
Expired
Date of Patent:
Nov. 22, 2016

Filed:

Jul. 12, 2013
Applicant:

Canadian Blood Services, Ottawa, CA;

Inventors:

Mark D. Scott, Surrey, CA;

Duncheng Wang, Vancouver, CA;

Wendy M. Toyofuku, Surrey, CA;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 63/00 (2006.01); A61K 35/14 (2015.01); A61K 35/17 (2015.01); C12N 5/0783 (2010.01); A61K 39/00 (2006.01); C12N 15/113 (2010.01); A61K 9/00 (2006.01); A61K 35/00 (2006.01); A61K 35/12 (2015.01); A61K 47/48 (2006.01);
U.S. Cl.
CPC ...
A61K 35/17 (2013.01); A61K 9/0019 (2013.01); A61K 35/14 (2013.01); A61K 39/001 (2013.01); A61K 39/0008 (2013.01); A61K 47/48776 (2013.01); C12N 5/0637 (2013.01); C12N 5/0638 (2013.01); C12N 15/113 (2013.01); A61K 35/00 (2013.01); A61K 47/48215 (2013.01); A61K 2035/122 (2013.01); A61K 2035/124 (2013.01); A61K 2039/515 (2013.01); A61K 2039/577 (2013.01); C12N 2310/141 (2013.01); C12N 2500/50 (2013.01); C12N 2501/00 (2013.01); C12N 2501/65 (2013.01); C12N 2502/1114 (2013.01);
Abstract

This invention relates to cellular-based therapies for increasing the level of regulatory T cells (Treg) and/or decreasing the level of pro-inflammatory T cells (Th17) to induce anergy or immune tolerance. To provide these therapeutic effects, two allogeneic leukocyte populations are contacted (in vivo, in vitro or ex vivo) and one of these leukocyte population is modified to bear on its surface a low-immunogenic biocompatible polymer so as to prevent pro-inflammatory allo-recognition. Cellular-based preparations and processes for achieving cellular therapy are also provided.


Find Patent Forward Citations

Scott, Mark. (2016). Method for inducing immune tolerance using viable polymer-modified allogeneic leukocytes (U.S. Patent No. 9498496). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9498496

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…